In most cases of acromegaly, this excessive growth hormone production stems from a noncancerous tumor in the pituitary gland. However, in rarer instances, the disease can be triggered by tumors ...

When Ray Kohn started feeling pain in his knees and elbows in 2015, he attributed it to his work as a stunt driver and ...

The novel consensus statement highlights current analytical pitfalls and the need to optimize disease control in acromegaly. Acromegaly is a serious endocrine disease associated with increased ...

Acromegaly is due to hypersecretion of growth ... Medical treatment of the disease is usually with somatostatin analogs. An open, prospective, single-center study by Maiza et al.

Acromegaly is a life-shortening disease where much of the morbidity is caused by insulin resistance, lipotoxicity, and cardiovascular events. Current therapies for acromegaly are associated with ...

The potential for new drug therapies, including combination treatments, presents significant growth opportunities in the acromegaly market. . Growing understanding of the disease's prevalence ...

A machine learning model was more accurate than 12 experienced endocrinologists in identifying adults with acromegaly based on voice recordings, according to findings published in The Journal of ...

In about 80% of families the gene causing the disease is unknown. The pituitary tumour types occurring in these families are most commonly growth hormone-secreting adenomas (causing acromegaly or ...

Each graph has 3 columns. The green column represents subjects who carry the AIP gene but not affected by the disease. The red bar represent subjects who have acromegaly/gigantism and harbour the ...